AMA Update for Aug. 31, 2023: The latest FDA naloxone approvals and Overdose Awareness Day with Bobby Mukkamala, MD
·
13 MIN READ

The latest FDA naloxone approvals and Overdose Awareness Day with Bobby Mukkamala, MD

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the current state of the overdose epidemic.

series
Overdose Epidemic
AMA Update
·
13 MIN READ

The latest FDA naloxone approvals and Overdose Awareness Day with Bobby Mukkamala, MD [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the current state of the overdose epidemic.

series
Overdose Epidemic
AMA Update Podcast
Doctor using stethoscope on a pregnant patient
·
5 MIN READ

Boosting treatment for incarcerated pregnant patients with SUDs

Pregnant people with a substance use disorder have the same right to treatment as any other person with an SUD. Learn more.

Overdose Epidemic
AMA in Action: Ending the overdose epidemic
UPDATED
·
5 MIN READ

Advocacy in action: Ending the overdose epidemic

Science, evidence and compassion must guide patient care and policy change to end the drug-overdose epidemic.

Overdose Epidemic
·
12 MIN READ

Naloxone: FDA approves over-the-counter Narcan nasal spray with Bobby Mukkamala, MD

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Narcan, the over-the-counter naloxone nasal spray, and more.

series
Overdose Epidemic
AMA Update
·
12 MIN READ

Naloxone: FDA approves over-the-counter Narcan nasal spray with Bobby Mukkamala, MD [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Narcan, the over-the-counter naloxone nasal spray, and more.

series
Overdose Epidemic
AMA Update Podcast
·
2 MIN READ

AMA statement on making naloxone available over the counter

The AMA strongly supports the FDA decision to make the opioid overdose-reversing drug naloxone available over the counter, a position we have long championed.

Press Releases
·
2 MIN READ

Jan. 27, 2023: Advocacy Update spotlight on buprenorphine prescribing

Buprenorphine prescribing now available to all DEA-registered physicians and more in the latest Advocacy Update spotlight.

Advocacy Update
·
2 MIN READ

Sept. 16, 2022: Advocacy Update spotlight on 2022 Overdose report

AMA 2022 Overdose Report shows worsening epidemic, need for all-hands approach and more in the latest Advocacy Update spotlight.

Advocacy Update